Institute for Atherosclerosis Research

The Institute for Atherosclerosis Research (IFAR) is a specialized research organization focused on the pathogenesis, diagnosis, and treatment of atherosclerosis and related cardiovascular diseases. Founded and led by Dr. Alexander Orekhov, the institute utilizes unique cell-based models to screen for anti-atherosclerotic compounds and investigate the role of modified low-density lipoproteins and mitochondrial mutations in plaque formation. IFAR offers diagnostic services, including the assessment of serum atherogenicity, and has developed natural-based therapeutic products such as Allicor. The organization operates at the intersection of academic research and commercial biotechnology, collaborating globally on cardiovascular health initiatives and drug discovery projects.